Dr Reddy's Lab to approach regulator for Sputnik Light as universal vaccination dose

Dr Reddy's Laboratories is hoping to go to a regulator for its single-dose Sputnik Light jab as booster dose for approvals by June-end or early July, a senior official of the city- based drug-maker said on Thursday. Deepak Sapra, CEO...

Dr Reddy's Labs Q4 outcome: consolidated profit tanks 76% YoY to Rs 88 crore

Dr Reddy's Laboratories on Thursday said its consolidated net profit for the quarter ended March 2022 dropped to 75.85 per cent to Rs 87.5 crore, compared with Rs 362.4 crore in the same quarter last year...

CCI clears Serum Institute Life Sciences-Biocon Biologics deal

The Competition Commission of India (CCI) has approved a proposed deal involving Serum Institute Life Sciences, Covidshield Technologies and Biocon Biologics. Once the deal is complete, Serum Institute Life Sciences Pvt Ltd will have about...

HempStreet partners with Gynica to boost combined R&D for women's health with cannabinoid-based phytomedicine

HempStreet, India's first research to retail venture in the ayurvedic cannabis sector has partnered with Gynica, an R&D company based out of Israel focused on changing the culture of gynaecological treatment through clinically proven...

Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy

Goldman Sachs is in advanced talks to invest about $350 million (Rs 2,700 crore) in API Holdings, the parent of online pharmacy PharmEasy, in a structured debt transaction, people in the know said...

AstraZeneca boosts COVID-19 portfolio with RQ Bio deal

AstraZeneca moved to bolster its COVID-19 portfolio of antibodies on Tuesday with a $157 million licensing deal for experimental therapies developed by newly-launched biotech RQ Bio...

Takeda launches hemophilia drug Adynovate in India

Takeda Pharma has expanded its innovative rare diseases portfolio in India with the launch of Adynovate, an innovative extended half-life recombinant Factor VIII (rFVIII) treatment, using established technology (controlled PEGylation)...

BDR Pharma raises Rs 685 crore from multiples, other investors

Drugmaker BDR Pharma has raised ₹685 crore from a consortium of investors led by private equity firm Multiples...

Solving the Riddle of Pharmaceutical Regulatory Compliance

Regulatory bodies throughout the world seek to protect public health and ensure the safety, effectiveness, and security of pharmaceuticals, biologics, and medical devices in their respective territories.

Halesaga launches new health and wellness products with Discounts

Halesaga, a prominent health and wellness brand, has announced the launch of a new line of wellness goods with a 5 per cent discount on prepaid orders...

© 2025 India Pharma Outlook. All Rights Reserved.